Drug-induced sarcoidosis-like reaction in the oral cavity: a case report
This study presents a rare case of DISR with oral involvement. A 63-year-old woman with a history of rheumatoid arthritis who has been treated with adalimumab presented with multiple ulcerative nodules on the hard palate, with 15 days of duration. Imaging exams did not exhibit any alteration. (Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics)
Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics - August 17, 2022 Category: ENT & OMF Authors: Carla Isabelly Rodrigues-Fernandes, Luiz Alcino Monteiro Gueiros, Thayn á Melo De Lima Morais, Pablo Agustin Vargas, Oslei Paes De Almeida, Márcio Ajudarte Lopes, Alan Roger Santos-Silva Source Type: research

Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulators
CONCLUSIONS: Biologics facing biosimilar competition may experience price decreases, potentially offering substantial savings to payers, patients, and society, although the magnitude of these estimates depends on biosimilar uptake. Formulary placement, along with manufacturer-payer dynamics, may also play a role in determining the impact on price and market uptake of biosimilars.PMID:35965481 | DOI:10.1080/13696998.2022.2113252 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - August 15, 2022 Category: Health Management Authors: Ervant J Maksabedian Hernandez Marlon Graf Alexandria Portelli Jason Shafrin Source Type: research

The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
ConclusionsWe found a significant change in eGFR over time, although this small decrease was not clinically relevant. This study further demonstrates that anti-TNF does not affect renal function in AS patients with and without existing risk factors for renal decline, which means that use of anti-TNF is safe concerning renal function in patients with AS.Key Points• Previous studies showed that biologicals, such as anti-tumor necrosis factor (anti-TNF), reduce cardiovascular disease (CVD) in patients with inflammatory rheumatic diseases, such as ankylosing spondylitis (AS).• Impaired renal function is a known predictor o...
Source: Clinical Rheumatology - August 12, 2022 Category: Rheumatology Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease
CONCLUSION: Higher maintenance infliximab and adalimumab trough levels are associated with perianal fistula healing in CD.PMID:35949350 | PMC:PMC9254145 | DOI:10.3748/wjg.v28.i23.2597 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - August 11, 2022 Category: Gastroenterology Authors: Bonita Gu Kavya Venkatesh Astrid-Jane Williams Watson Ng Crispin Corte Ali Gholamrezaei Simon Ghaly Wei Xuan Sudarshan Paramsothy Susan Connor Source Type: research